Portfolio company
Cellink
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This company develops 3D bioprinters and bioinks for researchers in academic, pharmaceutical and industrial laboratories to create human tissue models and organs.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Allevi
This company develops 3D bioprinters and bioinks for researchers in tissue engineering, drug development and regenerative medicine.
Volumetric | 3D Systems
This company develops bioprinting technologies and vascularised human tissues for pharmaceutical researchers and medical institutions conducting drug testing and organ replacement research.
Volumetric
This company develops 3D bioprinting platforms and biomaterials for healthcare researchers to create human organ replacements and vascularised tissue models for drug testing.
Cellbox Labs
This company develops automated organ-on-chip platforms for pharmaceutical firms to perform precise drug discovery and testing without using animal models.
Cellbricks
Cellbricks develops 3D-bioprinted human tissue implants and vascularised therapeutics for patients with complex wounds, soft tissue defects and organ damage.
Hooke Bio
This company develops a microfluidic platform using three-dimensional human tissue models for preclinical drug testing for pharmaceutical and biotechnology organisations.
Brinter
This company develops 3D-bioprinted regenerative medical implants for healthcare providers to treat patients requiring breast reconstruction and orthopedic repairs.
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
